Searchable abstracts of presentations at key conferences in endocrinology

ea0011p184 | Clinical practise and governance | ECE2006

Long-acting intramuscular testosterone undecanoate (TU, Nebido®) in treatment of hypogonadal aging males

Jacobeit JW , Schulte HM

Introduction: Over the last five years testosterone therapy in men became more safe, efficient and ‘patient-friendly’ with the introduction of new testosterone preparations. Testosterone gels are in widespread use, but they are associated with the risk of interpersonal transfer and need daily application. Recently, injectable testosterone undecanoate (TU, Nebido®) has become available in Europe.Long term data of aging males with...